Vis enkel innførsel

dc.contributor.authorManchia, Mirko
dc.contributor.authorVieta, Eduard
dc.contributor.authorSmeland, Olav Bjerkehagen
dc.contributor.authorAltimus, Cara
dc.contributor.authorBechdolf, Andreas
dc.contributor.authorBellivier, Frank
dc.contributor.authorBergink, Veerle
dc.contributor.authorFagiolini, Andrea
dc.contributor.authorGeddes, John R.
dc.contributor.authorHajek, Tomas
dc.contributor.authorHenry, Chantal
dc.contributor.authorKupka, Ralph
dc.contributor.authorLagerberg, Trine Vik
dc.contributor.authorLicht, Rasmus W.
dc.contributor.authorMartinez-Cengotitabengoa, Monica
dc.contributor.authorMorken, Gunnar
dc.contributor.authorNielsen, René E.
dc.contributor.authorPinto, Ana Gonzalez
dc.contributor.authorReif, Andreas
dc.contributor.authorRietschel, Marcella
dc.contributor.authorRitter, Philipp
dc.contributor.authorSchulze, Thomas G.
dc.contributor.authorScott, Janine Linda
dc.contributor.authorSeverus, Emanuel
dc.contributor.authorYildiz, Aysegul
dc.contributor.authorKessing, Lars Vedel
dc.contributor.authorBauer, Michael
dc.contributor.authorGoodwin, Guy M.
dc.contributor.authorAndreassen, Ole Andreas
dc.date.accessioned2021-02-24T08:49:26Z
dc.date.available2021-02-24T08:49:26Z
dc.date.created2021-01-25T12:44:40Z
dc.date.issued2020
dc.identifier.citationEuropean Neuropsychopharmacology. 2020, 36 121-136.en_US
dc.identifier.issn0924-977X
dc.identifier.urihttps://hdl.handle.net/11250/2729974
dc.description.abstractBipolar disorder (BD) is a major healthcare and socio-economic challenge. Despite its substantial burden on society, the research activity in BD is much smaller than its economic impact appears to demand. There is a consensus that the accurate identification of the underlying pathophysiology for BD is fundamental to realize major health benefits through better treatment and preventive regimens. However, to achieve these goals requires coordinated action and innovative approaches to boost the discovery of the neurobiological underpinnings of BD, and rapid translation of research findings into development and testing of better and more specific treatments. To this end, we here propose that only a large-scale coordinated action can be successful in integrating international big-data approaches with real-world clinical interventions. This could be achieved through the creation of a Global Bipolar Disorder Foundation, which could bring government, industry and philanthropy together in common cause. A global initiative for BD research would come at a highly opportune time given the seminal advances promised for our understanding of the genetic and brain basis of the disease and the obvious areas of unmet clinical need. Such an endeavour would embrace the principles of open science and see the strong involvement of user groups and integration of dissemination and public involvement with the research programs. We believe the time is right for a step change in our approach to understanding, treating and even preventing BD effectively.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleTranslating big data to better treatment in bipolar disorder - a manifesto for coordinated actionen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber121-136en_US
dc.source.volume36en_US
dc.source.journalEuropean Neuropsychopharmacologyen_US
dc.identifier.doi10.1016/j.euroneuro.2020.05.006
dc.identifier.cristin1878366
dc.description.localcodeThis is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal